Jain, P., Kantarjian, H., Ghorab, A., Sasaki, K., Jabbour, E., Gonzalez, G. N., . . . Cortes, J. (2017). Prognostic factors and survival outcomes in patients with blast phase CML (CML-BP) in the tyrosine kinase inhibitor (TKI) era: Cohort study of 477 patients. Cancer.

Jain, Preetesh, et al. "Prognostic Factors and Survival Outcomes in Patients With Blast Phase CML (CML-BP) in the Tyrosine Kinase Inhibitor (TKI) Era: Cohort Study of 477 Patients." Cancer 2017.

Jain, Preetesh, et al. "Prognostic Factors and Survival Outcomes in Patients With Blast Phase CML (CML-BP) in the Tyrosine Kinase Inhibitor (TKI) Era: Cohort Study of 477 Patients." Cancer 2017.